Filing Details

Accession Number:
0001140361-18-025010
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-21 18:25:28
Reporting Period:
2018-05-17
Accepted Time:
2018-05-21 18:25:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1435049 Aduro Biotech Inc. ADRO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1653641 Blaine Templeman C/O Aduro Biotech, Inc.
740 Heinz Avenue
Berkeley CA 94710
Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-05-17 2,000 $8.15 69,937 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2018.
  2. The shares sold were originally acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2018.